MHH-ES-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1411
|
Homo sapiens (Human)
|
Ewing sarcoma
|
Population: Caucasian., Part of: Ewing Sarcoma Cell Line Atlas (ESCLA)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919 PMID:22142829 PMID:22460905 PMID:25223734 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778 PMID:36476851
|
Cancer cell line
|
Male |
MHH-ES1, MHHES1 |
|
|
CLO:CLO_0007718, EFO:EFO_0006650, CLDB:cl3478, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:185, BioSample:SAMN03471911, BioSample:SAMN03473362, BioSample:SAMN10988548, cancercelllines:CVCL_1411, Cell_Model_Passport:SIDM00386, ChEMBL-Cells:CHEMBL3308762, ChEMBL-Targets:CHEMBL1075505, CLS:300136, Cosmic:908134, Cosmic:1718436, Cosmic:2250463, Cosmic-CLP:908134, DepMap:ACH-000391, DSMZ:ACC-167, DSMZCellDive:ACC-167, EGA:EGAS00001000610, GDSC:908134, GEO:GSM887318, GEO:GSM888394, GEO:GSM1670106, GEO:GSM5359670, GEO:GSM5359671, GEO:GSM5359672, GEO:GSM5359673, GEO:GSM5359674, GEO:GSM5359675, GEO:GSM5362922, GEO:GSM5362923, GEO:GSM5362924, GEO:GSM5362925, GEO:GSM5362926, GEO:GSM5362927, GEO:GSM5363976, GEO:GSM5363977, GEO:GSM5363978, GEO:GSM5363979, GEO:GSM5363980, IARC_TP53:21501, LiGeA:CCLE_341, LINCS_LDP:LCL-1454, PharmacoDB:MHHES1_928_2019, PRIDE:PXD030304, Progenetix:CVCL_1411, PubChem_Cell_line:CVCL_1411, Wikidata:Q54905539 |
|
|
CVCL_1411 |
2026-08-15 04:46:27 |
7 |
MIA PaCa-2
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0428
|
Homo sapiens (Human)
|
Pancreatic undifferentiated carcinoma
|
Caution: Additional TP53 mutation in c.818G>A indicated incorrectly in PubMed=1630814., Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:832918 PMID:1630814 PMID:1764370 PMID:7809022 PMID:7961102 PMID:8026879 PMID:8194712 PMID:9290701 PMID:10027410 PMID:11115575 PMID:11169957 PMID:11169959 PMID:11787853 PMID:12068308 PMID:12692724 PMID:14695172 PMID:15770730 PMID:16912165 PMID:17254797 PMID:18298655 PMID:18380791 PMID:18575732 PMID:19077451 PMID:19188929 PMID:19904223 PMID:20037478 PMID:20164919 PMID:20215515 PMID:20418756 PMID:21607521 PMID:22460905 PMID:22585861 PMID:23386380 PMID:25167228 PMID:25485619 PMID:25485960 PMID:25877200 PMID:25984343 PMID:26216984 PMID:26884312 PMID:27067801 PMID:27259358 PMID:27397505 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31037374 PMID:31068700 PMID:31978347 PMID:32782605 PMID:34207840 PMID:35839778
|
Cancer cell line
|
Male |
MIA-PaCa-2, MIA-PACA-2, MIA-Pa-Ca-2, MIA Paca2, MIA PaCa2, MiaPaCa-2, MIAPACA-2, MiaPaca.2, MiaPaCa2, Miapaca2, MIAPaCa2, MIAPACA2, Mia PACA 2, MIAPaCa-2, PaCa2, MiaPaCa, MIAMI Pancreatic Carcinoma-2 |
|
|
BTO:BTO_0002137, CLO:CLO_0007726, CLO:CLO_0050101, EFO:EFO_0002236, MCCL:MCC:0000325, CLDB:cl3480, CLDB:cl3481, CLDB:cl3482, AddexBio:C0018002/59, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3263, ArrayExpress:E-MTAB-3610, ATCC:CRL-1420, ATCC:CRM-CRL-1420, BCRC:60139, BCRJ:0174, BioGRID_ORCS_Cell_line:544, BioSample:SAMN01821579, BioSample:SAMN01821700, BioSample:SAMN03472131, BioSample:SAMN10988205, cancercelllines:CVCL_0428, CCRID:3101HUMSCSP568, CCRID:4201HUM-CCTCC00255, CCTCC:GDC0255, Cell_Model_Passport:SIDM00505, CGH-DB:321-1, CGH-DB:9374-4, ChEMBL-Cells:CHEMBL3308500, ChEMBL-Targets:CHEMBL614725, CLS:300438, Cosmic:707249, Cosmic:710861, Cosmic:719677, Cosmic:724644, Cosmic:724870, Cosmic:730532, Cosmic:808172, Cosmic:868243, Cosmic:872996, Cosmic:913313, Cosmic:918056, Cosmic:922249, Cosmic:923170, Cosmic:932520, Cosmic:947399, Cosmic:948373, Cosmic:948731, Cosmic:949234, Cosmic:968107, Cosmic:1006368, Cosmic:1066202, Cosmic:1108337, Cosmic:1198208, Cosmic:1299302, Cosmic:1320461, Cosmic:1366278, Cosmic:1477431, Cosmic:1534318, Cosmic:1571779, Cosmic:1609545, Cosmic:1644314, Cosmic:1995507, Cosmic:2434084, Cosmic:2664042, Cosmic:2668287, Cosmic:2755950, Cosmic-CLP:724870, DepMap:ACH-000601, DSMZ:ACC-733, DSMZCellDive:ACC-733, ECACC:85062806, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10488-107B2, FCS-free:216-2-440-1-3-6, GDSC:724870, GEO:GSM206526, GEO:GSM244425, GEO:GSM621895, GEO:GSM784703, GEO:GSM887320, GEO:GSM888396, GEO:GSM1024404, GEO:GSM1374677, GEO:GSM1374678, GEO:GSM1374679, GEO:GSM1435696, GEO:GSM1435697, GEO:GSM1435698, GEO:GSM1588612, GEO:GSM1588624, GEO:GSM1670109, GEO:GSM5481591, GEO:GSM5481592, GEO:GSM5481593, GEO:GSM5481594, IARC_TP53:316, IGRhCellID:MIAPaCa, IZSLER:BS TCL 42, JCRB:JCRB0070, KCLB:21420, LiGeA:CCLE_231, LINCS_LDP:LCL-1738, Lonza:751, MetaboLights:MTBLS812, NCBI_Iran:C459, PharmacoDB:MIAPaCa2_931_2019, PRIDE:PXD001260, PRIDE:PXD003198, PRIDE:PXD030304, Progenetix:CVCL_0428, PubChem_Cell_line:CVCL_0428, RCB:RCB2094, SKY/M-FISH/CGH:1996, TKG:TKG 0227, Wikidata:Q54905679 |
|
|
CVCL_0428 |
2026-08-15 04:46:23 |
1066 |
LCLC-97TM1
Resource Report
Resource Website
|
RRID:CVCL_1376
|
Homo sapiens (Human)
|
Lung large cell carcinoma
|
Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2840315 PMID:20164919 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26361996 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
LCLC97TM1, Large Cell Lung Cancer-97TM1 |
|
|
CLO:CLO_0007283, EFO:EFO_0006635, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:928, BioSample:SAMN03473042, BioSample:SAMN03473572, BioSample:SAMN10988572, cancercelllines:CVCL_1376, Cell_Model_Passport:SIDM00344, ChEMBL-Cells:CHEMBL3308112, ChEMBL-Targets:CHEMBL1075489, CLS:300409, Cosmic:946361, Cosmic:1146948, Cosmic:1995482, Cosmic-CLP:946361, DepMap:ACH-000596, DSMZ:ACC-388, DSMZCellDive:ACC-388, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:946361, GEO:GSM434288, GEO:GSM784234, GEO:GSM887265, GEO:GSM888340, GEO:GSM1670046, IARC_TP53:27176, IGRhCellID:LCLC97TM1GEO, LiGeA:CCLE_643, LINCS_LDP:LCL-1782, PharmacoDB:LCLC97TM1_834_2019, PRIDE:PXD002556, PRIDE:PXD030304, Progenetix:CVCL_1376, PubChem_Cell_line:CVCL_1376, Wikidata:Q54902346 |
|
|
CVCL_1376 |
2026-08-15 04:44:56 |
0 |
Li-7
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_3840
|
Homo sapiens (Human)
|
Adult hepatocellular carcinoma
|
Population: Japanese., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:85491 PMID:2542205 PMID:12029633 PMID:15767549 PMID:22460905 PMID:23887712 PMID:25877200 PMID:30784169 PMID:30894373 PMID:31063779 PMID:31068700 PMID:31378681 PMID:37610679
|
Cancer cell line
|
Male |
LI7, Li7, C-Li-7 |
|
|
CLO:CLO_0050854, ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:571, BioSample:SAMN03470992, BioSample:SAMN10987749, cancercelllines:CVCL_3840, CCRID:1101HUM-PUMC000678, CCRID:3101HUMSCSP5062, CCRID:3101HUMTCHu183, Cell_Model_Passport:SIDM01472, CGH-DB:9074-4, CLS:305102, Cosmic:721062, Cosmic:2023862, Cosmic:2162529, Cosmic:2771607, DepMap:ACH-000471, FANTOM5_SSTAR:10484-107A7, GEO:GSM565882, GEO:GSM887266, GEO:GSM888341, GEO:GSM2551577, IARC_TP53:30113, LiGeA:CCLE_219, LIMORE:Li7, PharmacoDB:Li7_835_2019, PRIDE:PXD002486, Progenetix:CVCL_3840, RCB:RCB1941, TKG:TKG 0368, Wikidata:Q54902491 |
|
|
CVCL_3840 |
2026-08-15 04:45:00 |
9 |
LNCaP
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0395
|
Homo sapiens (Human)
|
Prostate carcinoma
|
Population: Caucasian., Part of: ENCODE project common cell types; tier 3., Group: Space-flown cell line (cellonaut).
|
PMID:2734981 PMID:3335022 PMID:3518877 PMID:6831420 PMID:8687134 PMID:9018337 PMID:9090379 PMID:9460501 PMID:10702678 PMID:10972993 PMID:11135431 PMID:11172901 PMID:11304728 PMID:11414198 PMID:11416159 PMID:12606952 PMID:12725112 PMID:14518029 PMID:15162376 PMID:15486987 PMID:22213130 PMID:22278370 PMID:23671654 PMID:24587179 PMID:24618588 PMID:25485619 PMID:25877200 PMID:26256267 PMID:26589293 PMID:26972028 PMID:27036029 PMID:27141528 PMID:29194687 PMID:29233929 PMID:29660373 PMID:29739788 PMID:30787054 PMID:35502546 PMID:38892296
|
Cancer cell line
|
Male |
LNCAP, LNCap, Ln-Cap, LNCaP-RPCI, Lymph Node Carcinoma of the prostate |
|
|
BTO:BTO_0001321, CLO:CLO_0007365, CLO:CLO_0037116, EFO:EFO_0002071, MCCL:MCC:0000290, CLDB:cl3243, ArrayExpress:E-MTAB-2706, BioGRID_ORCS_Cell_line:182, BioSample:SAMN03472386, cancercelllines:CVCL_0395, CCRID:1101HUM-PUMC000040, CCTCC:GDC0283, CCTCC:GDC0284, ChEMBL-Cells:CHEMBL3307965, ChEMBL-Targets:CHEMBL612518, CLS:300265, Cosmic:704848, Cosmic:721368, Cosmic:721555, Cosmic:755298, Cosmic:759895, Cosmic:801348, Cosmic:850413, Cosmic:850745, Cosmic:850821, Cosmic:869155, Cosmic:918500, Cosmic:920967, Cosmic:921047, Cosmic:922553, Cosmic:923955, Cosmic:943176, Cosmic:948076, Cosmic:949248, Cosmic:1028648, Cosmic:1028701, Cosmic:1066237, Cosmic:1070886, Cosmic:1071481, Cosmic:1071906, Cosmic:1075275, Cosmic:1172626, Cosmic:1176618, Cosmic:1330909, Cosmic:1556120, Cosmic:1689708, Cosmic:1995486, Cosmic:2537792, Cosmic:2580128, Cosmic:2585151, Cosmic:2585228, Cosmic:2621168, Cosmic:2651770, Cosmic:2669169, Cosmic:2816221, DSMZ:ACC-256, DSMZCellDive:ACC-256, EGA:EGAS00001000610, GEO:GSE99795, GEO:GSM91927, GEO:GSM142457, GEO:GSM142458, GEO:GSM383948, GEO:GSM383953, GEO:GSM482669, GEO:GSM525800, GEO:GSM784790, GEO:GSM816634, GEO:GSM816637, GEO:GSM844579, GEO:GSM945240, GEO:GSM945282, GEO:GSM1022672, GEO:GSM1029460, GEO:GSM1029461, GEO:GSM1029462, GEO:GSM1029463, GEO:GSM1029464, GEO:GSM1029465, GEO:GSM1029466, GEO:GSM1029467, GEO:GSM1374622, GEO:GSM1374626, GEO:GSM2069518, GEO:GSM2069519, GEO:GSM2069520, GEO:GSM2069521, GEO:GSM2069522, GEO:GSM2069523, GEO:GSM2069524, GEO:GSM2069525, GEO:GSM2650017, GEO:GSM2650018, GEO:GSM2650019, GEO:GSM2650020, GEO:GSM2650021, GEO:GSM2650022, GEO:GSM3145602, GEO:GSM3145720, IARC_TP53:21076, LINCS_LDP:LCL-1298, Lonza:109, PharmacoDB:LNCAP_850_2019, PRIDE:PXD000953, PRIDE:PXD000985, PRIDE:PXD002107, PRIDE:PXD002395, PRIDE:PXD003105, PRIDE:PXD003262, PRIDE:PXD006561, PRIDE:PXD032264, Progenetix:CVCL_0395, PubChem_Cell_line:CVCL_0395, TOKU-E:3599, Wikidata:Q6459234 |
|
|
CVCL_0395 |
2026-08-15 04:45:09 |
3185 |
LN-229
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0393
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7693337 PMID:8509230 PMID:9842975 PMID:10416987 PMID:14614447 PMID:14655754 PMID:16697959 PMID:17595512 PMID:19365568 PMID:20504876 PMID:21406405 PMID:22460905 PMID:22570425 PMID:25485619 PMID:25772239 PMID:25877200 PMID:25894527 PMID:25984343 PMID:26496030 PMID:26589293 PMID:27397505 PMID:27412690 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
LN 229, LN229, LNT-229 |
|
|
BTO:BTO_0002004, CLO:CLO_0007363, EFO:EFO_0006637, MCCL:MCC:0000288, AddexBio:C0005017/4993, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2611, BioGRID_ORCS_Cell_line:929, BioSample:SAMN03471191, BioSample:SAMN03471692, BioSample:SAMN10987619, cancercelllines:CVCL_0393, Cell_Model_Passport:SIDM00684, ChEMBL-Cells:CHEMBL4295402, ChEMBL-Targets:CHEMBL4296459, CLS:305043, Cosmic:849861, Cosmic:1746958, Cosmic:1995485, Cosmic:2302323, Cosmic:2367492, Cosmic:2491102, Cosmic:2516025, Cosmic:2580915, Cosmic-CLP:1240169, DepMap:ACH-000595, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240169, GEO:GSM101615, GEO:GSM101616, GEO:GSM326200, GEO:GSM397665, GEO:GSM397666, GEO:GSM481416, GEO:GSM887270, GEO:GSM888345, GEO:GSM1374621, GEO:GSM1670049, GEO:GSM2113428, GEO:GSM2113429, GEO:GSM2113430, GEO:GSM2113431, IARC_TP53:30212, LiGeA:CCLE_871, LINCS_LDP:LCL-1354, Lonza:1322, PharmacoDB:LN229_841_2019, PRIDE:PXD000589, PRIDE:PXD003790, PRIDE:PXD030304, Progenetix:CVCL_0393, PubChem_Cell_line:CVCL_0393, Ubigene:YC-A021, Wikidata:Q54902771 |
|
|
CVCL_0393 |
2026-08-15 04:45:08 |
854 |
LN-18
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0392
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7211194 PMID:7693337 PMID:7732013 PMID:8509230 PMID:9842975 PMID:10416987 PMID:14614447 PMID:14655754 PMID:17595512 PMID:21406405 PMID:22460905 PMID:22570425 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26496030 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
LN 18, LN18, LN018 |
|
|
BTO:BTO_0002005, CLO:CLO_0007362, EFO:EFO_0006636, MCCL:MCC:0000287, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2610, BCRJ:0420, BioGRID_ORCS_Cell_line:410, BioSample:SAMN03471122, BioSample:SAMN10988197, cancercelllines:CVCL_0392, Cell_Model_Passport:SIDM00685, ChEMBL-Cells:CHEMBL4295405, ChEMBL-Targets:CHEMBL4296458, CLS:305822, Cosmic:849858, Cosmic:1746957, Cosmic:1995484, Cosmic:2302322, Cosmic:2367489, Cosmic:2491101, Cosmic-CLP:1240168, DepMap:ACH-000819, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240168, GEO:GSM326196, GEO:GSM397661, GEO:GSM397662, GEO:GSM887269, GEO:GSM888344, GEO:GSM1374620, GEO:GSM1670048, IARC_TP53:2570, LiGeA:CCLE_635, LINCS_LDP:LCL-1353, Lonza:1681, PharmacoDB:LN18_839_2019, PRIDE:PXD000589, PRIDE:PXD030304, Progenetix:CVCL_0392, PubChem_Cell_line:CVCL_0392, Wikidata:Q54902768 |
|
|
CVCL_0392 |
2026-08-15 04:45:08 |
37 |
MOLT-3
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0624
|
Homo sapiens (Human)
|
Adult T acute lymphoblastic leukemia
|
Karyotypic information: Hypertetraploid karyotype (ATCC=CRL-1552)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:1086134 PMID:2846092 PMID:2985879 PMID:3159941 PMID:3518877 PMID:3856477 PMID:3874327 PMID:4547172 PMID:4567231 PMID:6220172 PMID:6600440 PMID:6978176 PMID:7630190 PMID:8547074 PMID:8608962 PMID:9738977 PMID:9787181 PMID:9933131 PMID:10739008 PMID:11986953 PMID:12623853 PMID:15472075 PMID:17170727 PMID:20215515 PMID:25877200 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35354797
|
Cancer cell line
|
Male |
Molt-3, MOLT 3, Molt 3, MOLT3, Molt3 |
|
|
BTO:BTO_0001081, CLO:CLO_0007824, CLO:CLO_0051008, EFO:EFO_0005265, CLDB:cl3519, CLDB:cl3521, CLDB:cl3522, CLDB:cl3523, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ATCC:CRL-1552, BCRC:60106, BEI_Resources:ARP-12187, BioSample:SAMN03470846, BioSample:SAMN03471394, BioSample:SAMN03472164, BioSample:SAMN03473404, BioSample:SAMN10989586, cancercelllines:CVCL_0624, Cell_Model_Passport:SIDM00153, ChEMBL-Cells:CHEMBL3307556, ChEMBL-Targets:CHEMBL614176, CLS:300116, Cosmic:724815, Cosmic:850193, Cosmic:913410, Cosmic:999756, Cosmic:1191701, Cosmic:1281377, Cosmic:1524845, Cosmic:2301561, Cosmic:2361367, Cosmic:2602923, DepMap:ACH-000964, DSMZ:ACC-84, DSMZCellDive:ACC-84, ECACC:90021901, GEO:GSM236793, GEO:GSM236829, GEO:GSM5137730, IGRhCellID:MOLT3, IZSLER:BS TCL 44, JCRB:JCRB9048, LiGeA:CCLE_717, PharmacoDB:MOLT3_957_2019, PRIDE:PXD023662, Progenetix:CVCL_0624, PubChem_Cell_line:CVCL_0624, RCB:RCB1164, Wikidata:Q54906351 |
|
|
CVCL_0624 |
2026-08-15 04:46:40 |
7 |
MOLT-4
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0013
|
Homo sapiens (Human)
|
Adult T acute lymphoblastic leukemia
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
|
PMID:165156 PMID:1765142 PMID:2041050 PMID:2140233 PMID:2144611 PMID:2846092 PMID:2985879 PMID:3159941 PMID:3335022 PMID:3874327 PMID:4547172 PMID:4567231 PMID:6181032 PMID:6198871 PMID:6200433 PMID:6582512 PMID:6954533 PMID:8127147 PMID:8316623 PMID:8547074 PMID:8558913 PMID:8641406 PMID:8957066 PMID:9331090 PMID:9510473 PMID:9685479 PMID:9787181 PMID:10071127 PMID:10700174 PMID:10739008 PMID:11021758 PMID:11226526 PMID:11416159 PMID:11986953 PMID:12068308 PMID:15472075 PMID:15748285 PMID:15901131 PMID:16408098 PMID:16957166 PMID:17088437 PMID:17117183 PMID:19372543 PMID:20164919 PMID:20215515 PMID:20922763 PMID:22068913 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24670534 PMID:24762992 PMID:25877200 PMID:26295583 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:28569787 PMID:30894373 PMID:31068700 PMID:31160637 PMID:31733513 PMID:32449352 PMID:35354797 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Male |
Molt-4, MOLT 4, Molt 4, MOLT.4, MOLT4, Molt4, GM02219, GM02219C, GM2219C, GM02219D |
|
|
BTO:BTO_0000873, CLO:CLO_0007825, CLO:CLO_0032246, CLO:CLO_0050992, EFO:EFO_0001220, MCCL:MCC:0000335, CLDB:cl3524, CLDB:cl3525, CLDB:cl3527, CLDB:cl3528, CLDB:cl3529, CLDB:cl3530, CLDB:cl3531, CLDB:cl3532, CLDB:cl4976, CLDB:cl5233, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, ATCC:CRL-1582, BCRC:60060, BCRJ:0176, BioSample:SAMN03470847, BioSample:SAMN03471400, BioSample:SAMN03472410, BioSample:SAMN03473319, BioSample:SAMN10988202, cancercelllines:CVCL_0013, CCRID:1101HUM-PUMC000043, CCRID:3101HUMTCHu224, CCRID:4201HUM-CCTCC00083, CCTCC:GDC0083, Cell_Model_Passport:SIDM00145, ChEMBL-Cells:CHEMBL3307557, ChEMBL-Targets:CHEMBL614177, CLS:300115, Coriell:GM02219, Cosmic:716176, Cosmic:721716, Cosmic:801730, Cosmic:850194, Cosmic:850381, Cosmic:875865, Cosmic:897451, Cosmic:905958, Cosmic:913409, Cosmic:919154, Cosmic:922677, Cosmic:932766, Cosmic:933547, Cosmic:974249, Cosmic:991545, Cosmic:999763, Cosmic:1012099, Cosmic:1019314, Cosmic:1044254, Cosmic:1070704, Cosmic:1071877, Cosmic:1082518, Cosmic:1092615, Cosmic:1115596, Cosmic:1118467, Cosmic:1127263, Cosmic:1130237, Cosmic:1151788, Cosmic:1175131, Cosmic:1175857, Cosmic:1176596, Cosmic:1226858, Cosmic:1305339, Cosmic:1312325, Cosmic:1330500, Cosmic:1483362, Cosmic:1509200, Cosmic:1524808, Cosmic:1639636, Cosmic:1664513, Cosmic:1811158, Cosmic:1998457, Cosmic:2039521, Cosmic:2165720, Cosmic:2361368, Cosmic:2560251, Cosmic:2602924, Cosmic-CLP:905958, dbMHC:48976, DepMap:ACH-001127, DSMZ:ACC-362, DSMZCellDive:ACC-362, ECACC:85011413, ECACC:94022544, EGA:EGAS00001000978, GDSC:905958, GEO:GSM2092, GEO:GSM50196, GEO:GSM50912, GEO:GSM236794, GEO:GSM236830, GEO:GSM743460, GEO:GSM750821, GEO:GSM799348, GEO:GSM799411, GEO:GSM887336, GEO:GSM888412, GEO:GSM1178423, GEO:GSM1178424, GEO:GSM1178425, GEO:GSM1181333, GEO:GSM1181349, GEO:GSM1670128, GEO:GSM1696583, GEO:GSM1696584, GEO:GSM1696585, GEO:GSM1696586, GEO:GSM2124644, GEO:GSM4471876, GEO:GSM5137731, GEO:GSM7701445, GEO:GSM7701446, IARC_TP53:27042, ICLC:HTL99025, IGRhCellID:MOLT4, IHW:IHW09226, IPD-IMGT/HLA:11094, IZSLER:BS TCL 85, JCRB:IFO50362, JCRB:JCRB9031, KCB:KCB 200940YJ, KCLB:21582, LINCS_LDP:LCL-1019, Lonza:810, NCBI_Iran:C149, NCI-DTP:MOLT-4, PharmacoDB:MOLT4_958_2019, PRIDE:PXD003539, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD018565, PRIDE:PXD023662, PRIDE:PXD030304, Progenetix:CVCL_0013, PubChem_Cell_line:CVCL_0013, RCB:RCB0206, SKY/M-FISH/CGH:2741, Ubigene:YC-C127, Wikidata:Q54906365 |
|
|
CVCL_0013 |
2026-08-15 04:46:41 |
318 |
MOR
Resource Report
Resource Website
|
RRID:CVCL_2618
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian.
|
PMID:3034934 PMID:7171457 PMID:7903701 PMID:25485619 PMID:25877200 PMID:26589293
|
Cancer cell line
|
Sex unspecified |
MOR/P |
|
|
EFO:EFO_0006655, ArrayExpress:E-MTAB-2706, BioSample:SAMN03472982, Cell_Model_Passport:SIDM01390, ECACC:84112312, EGA:EGAS00001000610, EGA:EGAS00001002554, PharmacoDB:MOR_961_2019, Wikidata:Q54906387 |
|
|
CVCL_2618 |
2026-08-15 04:46:42 |
0 |
MOR
Resource Report
Resource Website
|
ECACC Cat# 84112312, RRID:CVCL_2618
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian.
|
PMID:3034934 PMID:7171457 PMID:7903701 PMID:25485619 PMID:25877200 PMID:26589293
|
Cancer cell line
|
Sex unspecified |
MOR/P |
ECACC |
84112312 |
EFO:EFO_0006655, ArrayExpress:E-MTAB-2706, BioSample:SAMN03472982, Cell_Model_Passport:SIDM01390, ECACC:84112312, EGA:EGAS00001000610, EGA:EGAS00001002554, PharmacoDB:MOR_961_2019, Wikidata:Q54906387 |
|
|
CVCL_2618 |
2026-08-15 04:46:42 |
0 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
AddexBio Cat# T0016002/4922, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
AddexBio |
T0016002/4922 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-08-15 04:46:46 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
JCRB Cat# IFO50073, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
JCRB |
IFO50073 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-08-15 04:46:46 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
JCRB Cat# JCRB9008, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
JCRB |
JCRB9008 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-08-15 04:46:46 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
CCTCC Cat# GDC0032, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
CCTCC |
GDC0032 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-08-15 04:46:46 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
NCBI_Iran Cat# C125, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
NCBI_Iran |
C125 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-08-15 04:46:46 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
KCB Cat# KCB 200412YJ, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
KCB |
KCB 200412YJ |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-08-15 04:46:46 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
KCB Cat# KCB 89023YJ, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
KCB |
KCB 89023YJ |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-08-15 04:46:46 |
2876 |
MR6
Resource Report
Resource Website
|
RRID:CVCL_U183
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Population: African American.
|
PMID:2372878 PMID:3608093 PMID:25877200
|
Cancer cell line
|
Female |
|
|
|
CLO:CLO_0050916, BioSample:SAMN03470988, BioSample:SAMN03472275, RCB:RCB0505, Wikidata:Q54906577 |
cvcl_u209 |
|
CVCL_U183 |
2026-08-15 04:46:46 |
0 |
MR1-3
Resource Report
Resource Website
|
RCB Cat# RCB0504, RRID:CVCL_U180
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Population: African American.
|
PMID:2372878 PMID:3608093 PMID:25877200
|
Cancer cell line
|
Female |
|
RCB |
RCB0504 |
CLO:CLO_0050915, BioSample:SAMN03470994, Cosmic:753593, RCB:RCB0504, Wikidata:Q54906568 |
cvcl_u209 |
|
CVCL_U180 |
2026-08-15 04:46:46 |
0 |